Hypertension in the ElderlyL. Michael Prisant Springer Science & Business Media, 5 nov 2007 - 532 páginas A comprehensive review of all aspects of hypertension in the elderly using the most current clinical data. Topics range from basic concepts, epidemiology and trials, and evaluation and management, to pharmacologic treatment, special populations, and adherence, all presented with an emphasis on the optimal management of patients. The authors examine in detail the mechanisms of hypertension in the elderly, the lifestyle trials and outcomes trials that were conducted in older persons, as well as the problems of clinical evaluation, secondary hypertension, adherence, and target organ damage. Extensive discussions of pharmacologic therapy detail the role of all the major drug classes. |
Índice
| 11 | |
Aging Arterial Stiffness and Systolic Hypertension | 23 |
Pharmacological and Pharmacodynamic Alterations | 35 |
Epidemiology of Hypertension in the Older Patient | 53 |
Nonpharmacological Trials in the Older | 69 |
Clinical Trials of Hypertension in the Older | 91 |
Blood Pressure Measurement in Older Patients | 119 |
Diagnosis and Management of Hypertensive Renal | 171 |
Use of Angiotensin Receptor Blockers | 349 |
Clinical Trials With Calcium Antagonists in Older | 369 |
of Hypertension in the Elderly 381 James L Pool | 381 |
Combination Drug Therapy in the Elderly | 399 |
Attitudes Regarding Hypertension Among Older | 429 |
Treatment of Hypertension in the Elderly Patient | 451 |
Management of Hypertension in Older Patients | 471 |
ADHERENCE | 493 |
Ischemic Heart Disease in the Older Hypertensive | 229 |
Diuretics and βAdrenergic Blockers | 297 |
Assessment of the Role of ACE Inhibitors | 321 |
Otras ediciones - Ver todo
Términos y frases comunes
ACE inhibitors achieve active addition agents ALLHAT Americans antihypertensive arterial stiffness artery associated benefit blockers blood pressure calcium antagonists captopril cardiac cardiovascular cause changes chlorthalidone chronic Clin clinical combination compared coronary daily death decline decrease dementia diabetes diastolic difference disease diuretic dose double-blind drug effects elderly patients elevated Engl enzyme et al Evaluation factors goal greater heart failure higher hypertensive patients hypothyroidism important improve incidence increased individuals infarction initial Intern intervention isolated JAMA kidney Lancet less levels losartan lower major mean measurement medications mmHg morbidity mortality myocardial myocardial infarction normal occur older patients outcomes placebo population prevalence Prevention primary ramipril randomized received reduction renal reported response risk significant sodium stroke subjects suggested systolic hypertension therapy tion treated treatment trial vascular weeks women